Danske Bank A/S Teva Pharmaceutical Industries LTD Transaction History

Danske Bank A/S

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 19, 2025	BUY	$15.38 - $20.2 $3.82 Million - $5.01 Million	248,139 New	248,139 $5.01 Million
Q2 2025 Dec 18, 2025	BUY	$12.82 - $18.15 $267,938 - $379,334	20,900 Added 8.72%	260,539 $4.37 Million
Q1 2025 Dec 18, 2025	SELL	$14.67 - $22.01 $124,695 - $187,085	-8,500 Reduced 3.43%	239,639 $3.68 Million

673

616M

30.8M

18.5M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $28.2B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Danske Bank A/S, based on Form 13F filings with the SEC.

Stay updated on Danske Bank A/S with notifications on news.